tbuckley/cabot-search huggingface dataset:
A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE)
Authors: Robert Weinkove, Philip George, Robert Fyfe, Nathaniel Dasyam, Yasmin Nouri, Tess Ostapowicz, Stefan Mullins, Brigitta Mester, Giulia Giunti, Catherine M. Bollard, Travis Perera, Hayden Jina, Alwyn D'Souza, Le Qin, David S. Ritchie, Chris M.A. Frampton, Rachel Perret, Peng Li, Ian Hermans
Journal: Blood (2023)
A Phase I/II Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of Glofitamab As Monotherapy and in Combination with R-ICE Chemoimmunotherapy in Children and Young Adults with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (iMATRIX-GLO)
Authors: Birgit Burkhardt, Gianluca Rossato, Mark Dixon, David John Carlile, Steven Dmytrasz, Jade Wulff, Raluca Negricea, Beate Wulff
Journal: Blood (2023)
Is the Eutos Long Term Survival (ELTS) Score a Useful Marker to Predict Outcome in Children with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)? the Experience of the International Registry of Childhood CML
Authors: Frederic Millot, Joe De Keizer, Markus Metzler, Meinolf Suttorp, Petr Sedlacek, Maaike Luesink, Frankie WT Cheng, Krzysztof Kalwak, Birgitte Lausen, Gordana Jakovljevic, Barbara De Moerloose, Michael Dworzak, Marina Borisevich, Julia Yajima, Mirella Ampatzidou, Roula Farah, Emilia Kaiserova, Adalet Meral Günes, Andre Baruchel
Journal: Blood (2023)
Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the ENGOT-ov48/Eudario Trial
Authors: Christopher Maximilian Arends, Klara Kopp, Natalia Estrada-Barreras, Raphael Hablesreiter, Nicole Concin, Ute Moll, Robert Zeilinger, Wolfgang Schmitt, Jalid Sehouli, Hagen Kulbe, Isabelle Ray-Coquard, Alain Zeimet, Francesco Raspagliesi, Claudio Zamagni, Ignace Vergote, Domenica Lorusso, Lars Bullinger, Elena Ioana Braicu, Frederik Damm
Journal: Blood (2023)
Loss of 12-Lipoxygenase Improves the Post-Transfusion Function of Stored Platelets
Authors: Hannah Larsen, Daire Byrne, Hasan Tahsin Ozpolat, Aastha Chauhan, Shawn Bailey, Nicole Rhoads, Franklin Reed, Massiel Chavez Stolla, Raymond Adili, Michael Holinstat, Xiaoyun Fu, Moritz Stolla
Journal: Blood (2023)
Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma
Authors: Benjamin R Puliafito, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Melanie Ayala Ceja, Christy Sidhu, Thomas Schweppe, Beata Berent-Maoz, Stanley B Gosliner, Amr Almaktari, Karla Nawaly, Martin S Allen-Auerbach, Jonathan Said, Monica Mead, Sven de Vos, Patricia A. Young, Caspian H. Oliai, Gary J. Schiller, John Timmerman, Antoni Ribas, Yvonne Y Chen, Sarah M. Larson
Journal: Blood (2023)
High-Throughput Plasma Proteomics to Define the Precursor Multiple Myeloma Proteome and Identify Candidate High-Risk Disease Biomarkers of Progression
Authors: Elizabeth D. Lightbody, D. R. Mani, Hasmik Keshishian, Habib El-Khoury, Ankit K. Dutta, Hadley Barr, Namrata Udeshi, Luca Bertamini, Nang Kham Su, Cody J. Boehner, Laura Hevenor, Katherine Towle, Grace Fleming, Christian Cea-Curry, Jacqueline Perry, Erica M. Horowitz, Maya Davis, Annie Cowan, Catherine R. Marinac, Michael Gillette, Steven A. Carr, Irene M. Ghobrial
Journal: Blood (2023)
<i>T</i> <i>rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence</i>
Authors: Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Amé, Marion Simonet, Hyacinthe A. Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Ludovic Fouillet, Stéphane Morisset, Isabelle Tigaud, Romaine Mayet, Gwenaëlle Garin, Jérôme Guitton, Stéphanie Dulucq, Françoise Huguet
Journal: Blood (2023)
ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China
Authors: Jianyu Weng, Xin Huang, Ping Wu, Chengxin Deng, Minming Li, Xiaomei Chen, Chengwei Luo, Hui Zeng, Yuming Zhang, Caixia Wang, Tingfen Deng, Lie Lin, Zhenqian Huang, Bingyi Wu, Guozheng Wang, Runhui Zheng, Xu Ye, Peilong Lai, Yang Liang, Huo Tan, Yangqiu Li, Xin Du
Journal: Blood (2023)
Single Cell Analysis of Bone Marrow Stromal Cells Shows That a Pro-Inflammatory and Stress Response Together with Polarized Differentiation of Stromal Elements Characterize the Bone Marrow Microenvironment during Multiple Myeloma Development
Authors: Hussein Ghamlouch, Dylan Gagler, Patrick Blaney, Eileen Boyle, Yubao Wang, Liming Hou, Ola Landgren, Francesco Maura, Aristotelis Tsirigos, Gareth J. Morgan, Faith E. Davies
Journal: Blood (2023)
Characterization of Multiple Myeloma Subpopulations Associated with Treatment Resistance By Single-Cell RNA Sequencing
Authors: Takahiro Kamiya, Motohiko Oshima, Shuhei Koide, Yaeko Nakajima-Takagi, Kazumasa Aoyama, Satoshi Kaito, Naoki Itokawa, Masayuki Yamashita, Noriko Doki, Keisuke Kataoka, Atsushi Iwama
Journal: Blood (2023)
Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids to Model Hematopoietic Development
Authors: Stephanie Frenz-Wiessner, Savannah Fairley, Maximilian Buser, Isabel Goek, Kirill Salewskij, Gustav Jonsson, Benedicta zu Putlitz, Daniel Petersheim, David Illig, Yue Li, Pin-Hsuan Chen, Martina Kalauz, Raffaele Conca, Michael Sterr, Johanna Geuder, Yoko Mizoguchi, Daniel Kotlarz, Martina Rudelius, Josef M Penninger, Carsten Marr, Christoph Klein
Journal: Blood (2023)
Multinational Retrospective Analysis of Bridging Therapy Prior to Chimeric Antigen Receptor T Cells for Relapsed/Refractory Acute Lymphoblastic Leukemia in Children and Young Adults
Authors: Maike Breidenbach, Peter Bader, Andishe Attarbaschi, Claudia Rossig, Roland Meisel, Markus Metzler, Marion Subklewe, Fabian Mueller, Paul-Gerhardt Schlegel, Irene Teichert von Lüttichau, Jean-Pierre Bourquin, Gabriele Escherich, Gunnar Cario, Peter Lang, Ramona Krauss, Arend von Stackelberg, Semjon Willier, Christina Peters, Tobias Feuchtinger
Journal: Blood (2023)
Bridging Radiotherapy for Patients with Limited (&amp;lt;5 Disease Sites) Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Prior to CAR T-Cell Therapy
Authors: Omran Saifi, William Breen, Scott Lester, William Rule, Bradley Stish, Allison C. Rosenthal, Javier Munoz, Yi Lin, Patrick B Johnston, Stephen M Ansell, Jonas Paludo, Arushi Khurana, Jose. C. Villasboas, Yucai Wang, Madiha Iqbal, Muhamad Alhaj Moustafa, Hemant S. Murthy, Ernesto Ayala, Mohamed A. Kharfan-Dabaja, Jennifer Peterson, Bradford Hoppe
Journal: Blood (2023)
Mesenchymal Stromal Cells from Individuals with <i>DNMT3A mut</i> Clonal Hematopoiesis Instruct Young Healthy Hematopoietic Stem/Progenitor Cells Towards a Myeloid-Biased Aging Phenotype Resembling That of Patients with Clonal Cytopenia of Undetermined Significance (CCUS)
Authors: Anna Navarro Figueredo, Wencke Walter, Jennifer Rivière, Marit Leilich, Siddhi Pawar, Michèle Buck, Judith S. Hecker, Marta Benegas Coll, Carolina Monzó, Maki Sakuma, Priyansh Srivastava, Ana Conesa, Torsten Haferlach, Mark Van Der Garde, Katharina S. Götze
Journal: Blood (2023)
Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial
Authors: Mingzhi Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yu Chang, Xudong Zhang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Xiyang Liu, Xiaolong Wu, Liqun Zou, Hui Zhou, Hongwei Xue
Journal: Blood (2023)
Mega-Dose Decitabine Intensified Regimen Is More Effective at Eliminating Pre-HSCT Measurable Residual Disease Compared to the Bu/Cy Regimen: A Multicenter Prospective Phase II Study
Authors: Hao Zheng, Meng Lv, Chenhua Yan, Jing Liu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiao-Jun Huang
Journal: Blood (2023)
Artificial Intelligence Derived Changes between Baseline and Interim FDG-PET/CT Radiomics Features Are Associated with Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL)
Authors: Jacob Shreve, Allison M. Bock, Izel Okcu, Antonious Hazim, Joshua C Pritchett, Raphael Mwangi, Matthew J. Maurer, Mithun V Shah, Yucai Wang, Stephen M Ansell, Thomas M. Habermann, Thomas E. Witzig, James R. Cerhan, Jason R Young, Moritz Binder, Grzegorz S. Nowakowski, Jonas Paludo
Journal: Blood (2023)
Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AML
Authors: Sjoerd J.F. Hermans, Jurjen Versluis, Yvette van Norden, Erik D. van Werkhoven, Jeroen J.W.M. Janssen, Gerwin A. Huls, Bob Lowenberg, Thomas Pabst, Dimitri A. Breems, Elizabeth Berkx, Avinash G. Dinmohamed, Peter C. Huijgens, Eric Sträng, Jesús María Hernández-Rivas, Hartmut Döhner, Marta Sobas, Lars Bullinger, Rosa Ayala, Joaquin Martinez-Lopez, Klaus H Metzeler, Torsten Haferlach, Christian Thiede, Carin A. Uyl-De Groot, Gert J. Ossenkoppele, Francesco Pignatti, Jan J. Cornelissen
Journal: Blood (2023)
Clinical and Prognostic Implications of <i>WT1</i> Mutations in De Novo and Relapsed Acute Myeloid Leukemia
Authors: Himachandana Atluri, Jeremy DiGennaro, Keyur P. Patel, Mark Routbort, Betul Oran, Ghayas C. Issa, Nicholas J. Short, Naval Daver, Tapan M. Kadia, Farhad Ravandi, Uday R. Popat, Richard E. Champlin, Elizabeth J. Shpall, Sherry Pierce, Rashmi Kanagal-Shamanna, Chi Young Ok, Guilin Tang, Sa A. Wang, Raja Luthra, Audrey Lasry, Bettina Nadorp, Antonia Chroni, Ann-Kathrin Eisfeld, Iannis Aifantis, Najla H Al Ali, David A Sallman, Jeffrey Lancet, Onyee Chan, Eric Padron, Zhuoer Xie, L. Jeffrey Medeiros, Courtney D. DiNardo, Rami S. Komrokji, Sanam Loghavi
Journal: Blood (2023)
Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study
Authors: Ibrahim Aldoss, Josep-Maria Ribera, Hagop Kantarjian, Pau Montesinos, Jessica T. Leonard, David Gomez-Almaguer, Maria R. Baer, Carlo Gambacorti-Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Meliessa Hennessy, Niti Patel, Alexander Vorog, Bingxia Wang, Elias Jabbour
Journal: Blood (2023)
Phase 1 Study of SC291, a Hypoimmune, Allogeneic CD19-Directed CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies (ARDENT) - Initial Clinical Data
Authors: Sattva S. Neelapu, L. Elizabeth Budde, Joseph P McGuirk, Saurabh Dahiya, Abhinav Deol, Philip A. Thompson, Nitin Jain, Matthew A Lunning, Xiaomeng Hu, Boris Gorovits, Danielle Quarles, Barbara Metallo, Meghan Flaherty, Weidong Zhang, Hosein Kouros-Mehr, Terry J. Fry, Sonja Schrepfer
Journal: Blood (2023)
Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL
Authors: Anthony N. Audino, Stanton Goldman, Matthew J. Barth, Jessica Hochberg, Ana C. Xavier, Bruce Shiramizu, Qiuhu Shi, Lauren Harrison, Jackie Basso, Javier Oesterheld, Kenneth Matthew Heym, Richard A. Drachtman, Paul Harker-Murray, Sherrie L. Perkins, Rodney R. Miles, Mitchell S. Cairo
Journal: Blood (2023)
Trends in Access to Cellular Therapies in Multiple Myeloma (TACTUM): Perspectives of Treating Versus Referring Physicians
Authors: Rawan Atallah, Md Saiful Islam Saif, Danai Dima, Anuj Shrestha, Faiz Anwer, Muhammad Umair Mushtaq, Forat Lutfi, Leyla Shune, Hamza Hashmi, Siddhartha Ganguly, Joseph P McGuirk, Shebli Atrash, Al-Ola Abdallah, Rahul Banerjee, Nausheen Ahmed
Journal: Blood (2023)
EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab with Rituximab and Lenalidomide (R 2) Vs R 2 Alone in Patients with Relapsed or Refractory Follicular Lymphoma
Authors: Lorenzo Falchi, Franck Morschhauser, Kim Linton, Huiqiang Huang, Faith Galderisi, Syed Quadri, Lingmin Zeng, Daniela Hoehn, John F. Seymour
Journal: Blood (2023)
CEBPA-Driven Expression of the Transcriptionally Inactive deltaTP73 Isoform Phenocopies <i>TP53</i>mutated Poor Risk and Drug-Resistant Acute Myeloid Leukemia
Authors: Diego Pereira-Martins, César Alexander Ortiz Rojas, Isabel Weinhaeuser, Bart-Jan Wierenga, Vincent Van Den Boom, Fatemeh Mojallali, Dominique Sternadt, Thiago Mantello Bianco, Nisha van der Meer, Douglas RA Silveira, Lynn Quek, Emanuele Ammatuna, Antonio R Lucena-Araujo, Gerwin A. Huls, Eduardo Magalhães Rego, Jan Jacob Schuringa
Journal: Blood (2023)
The Cs a and Cs b Red Cell Antigens of the Cost Blood Group Collection Correspond to the HNA-3a and HNA-3b Neutrophil Antigens: Unexpected Twins with Implications for Sickle Cell Anemia
Authors: Jonathan De Oliveira Rios, Alisa Soudry, Romain Duval, Alexandre Raneri, Thomas Poyot, Jérome Babinet, Mariane De Montalembert, Claudia Regina Bonini Domingos, Caroline Le Van Kim, Marc Romana, Thierry Peyrard, Slim Azouzi
Journal: Blood (2023)
Valemetostat for Relapsed or Refractory B-Cell Lymphomas: Primary Results from a Phase 1 Trial
Authors: Koji Izutsu, Kenji Ishitsuka, Dai Maruyama, Kunihiro Tsukasaki, Shigeru Kusumoto, Yasuyuki Kakurai, Hideyuki Yamauchi, Ai Inoue, Masaya Tachibana, Shinji Tsutsumi, Kensei Tobinai
Journal: Blood (2023)
Evaluating Multidisciplinary Bone Marrow Failure Care (EMBRACE) - a Hybrid Implementation-Effectiveness Study
Authors: Lucy C. Fox, Nicole Den Elzen, Laura Barth, Kelsey Man, Paul James, Jillian Francis, Lin Cheng, Karin A Thursky, Ashish Bajel, David S. Ritchie, Piers Blombery
Journal: Blood (2023)
Mosunetuzumab Plus Polatuzumab Vedotin Demonstrates a Favorable Safety Profile and Efficacy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Primary Analysis of a Phase Ib/II Study
Authors: L. Elizabeth Budde, Adam J Olszewski, Sarit Assouline, Izidore S. Lossos, Catherine Diefenbach, Manali Kamdar, Nilanjan Ghosh, Dipenkumar Modi, Waleed Sabry, Seema Naik, Amitkumar Mehta, Shazia K. Nakhoda, Stephen D Smith, Kathleen Dorritie, Ting Jia, Song Pham, Ling-Yuh Huw, Hao Wu, Iris To, Michael C. Wei, Julio C. Chavez
Journal: Blood (2023)
Allogeneic Hematopoietic Stem Cell Transplantation in Advanced Systemic Mastocytosis
Authors: Deborah Christen, Johannes Lübke, Anne Kaiser, Juliana Schwaab, Khalid Shoumariyeh, Madlen Jentzsch, Katja Sockel, Judith Schaffrath, Francis A. Ayuk, Matthias Stelljes, Inken Hilgendorf, Elisa Sala, Jennifer Kaivers, Stefan Schönland, Christoph Wittke, Bernd Hertenstein, Markus P. Radsak, Ulrich Kaiser, Valeska Brückl, Nicolaus Kröger, Stefan Klein, Wolf-Karsten Hofmann, Tim H. Brümmendorf, Edgar Jost, Jens Panse, Andreas Reiter
Journal: Blood (2023)
Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelodysplastic Neoplasms Allografted with an Unrelated Donor: A Registry Study of the Chronic Malignancies Working Party of the EBMT
Authors: Yves Chalandon, Dirk-Jan Eikema, Ivan Sergeevich Moiseev, Fabio Ciceri, Linda Koster, Jan Vydra, Jakob R. Passweg, Montserrat Rovira, Mutlu Arat, Tobias Gedde-Dahl, Nicolaus Kröger, Victoria Potter, Ibrahim Yakoub-Agha, Alessandro Rambaldi, Maija Itäla-remes, Alina Daniela Tanase, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Donal P McLornan, Marie Robin
Journal: Blood (2023)
Zr Study: A Prospective Phase II Study of Zanubrutinib-Rituximab Chemo-Free Therapy with or without Autologous Stem Cell Transplantation in Newly Diagnosed Mantle Cell Lymphoma
Authors: Changju Qu, Nana Ping, Rui Zou, Jiajie He, Qian Zhu, Xiao Zhang, Fan Xia, Danqing Kong, Depei Wu, Zhengming Jin
Journal: Blood (2023)
Impact of Publicly Reported Center Specific Analysis on Patient Selection Practices for Hematopoietic Stem Cell Transplantation
Authors: Christopher Strouse, Mark Juckett, Brent R. Logan, Noel Estrada-Merly, Jaime M. Preussler, Tony Truong, Jesse Troy, Nandita Khera, William Wood, Hemalatha G. Rangarajan, Luke Akard, Neel S. Bhatt, Akshay Sharma, Wael Saber
Journal: Blood (2023)
KP104, a Bifunctional C5 Antibody/Factor H Fusion Protein, Effectively Controls Both Intravascular and Extravascular Hemolysis: Interim Results from a Phase 2 Study in Complement Inhibitor-Naïve PNH Patients
Authors: Fengkui Zhang, Li Zhang, Chen Yang, Chunrong Wang, Changhe Yue, Hui Yan, Jay Ma, Helen Fu, Chaomei He, Ping Tsui, Jingtao Wu, Richard Lee, Wenru Song, Bing Han
Journal: Blood (2023)
Adult Patients with Hemophilia B and with a History of Chronic HCV/HBV Infection Receiving Liver-Directed Gene Therapy Demonstrated Long-Term Bleeding Protection and Sustained FIX Activity: Efficacy and Safety Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec
Authors: Annette von Drygalski, Niamh O'Connell, Peter Verhamme, Karina Meijer, Paul van der Valk, Rashid Saeed Kazmi, Priyanka Raheja, Nicholas Galante, Sandra LeQuellec, Rachel Church, Samantha Lucas, Giancarlo Castaman, Paul Monahan
Journal: Blood (2023)
Subcutaneous (SC) Mosunetuzumab (mosun) As First-Line Therapy for Patients (pts) with High Tumor-Burden Follicular Lymphoma (FL): First Results of a Multicenter Phase 2 Study
Authors: Lorenzo Falchi, Michelle Okwali, Paola Ghione, Colette Owens, Paul A. Hamlin, Jennifer Kimberly Lue, Zachary D. Epstein-Peterson, Maria Lia Palomba, Anita Kumar, Pallawi Torka, Lori A. Leslie, Alexandra Ferreira Lopes, Anastasia Martinova, Lauren Wood, Clare Grieve, Walter Ramos Amador, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles
Journal: Blood (2023)
Assessment of Inpatient Mortality in the Peri-Transplant Period in Elderly Allogeneic Stem Cell Transplant Recipients with Co-Existing Mental Health Illnesses
Authors: Shivani Sharma, Arcita Hanjani Pramudita, Suma Sri Chennapragada, Hemamalini Sakthivel, Poornima Ramadas, Kamleshun Ramphul, Roman M. Shapiro
Journal: Blood (2023)
Repurposing GSK3B Small Molecule Inhibitors for Refractory Lymphoid Malignancies
Authors: Kadriye Nehir Cosgun, Mark E Robinson, Salim Oulghazi, Liang Xu, Gang Xiao, Lai N Chan, Jaewoong Lee, Kohei Kume, Etienne Leveille, David Fonseca Arce, Dhruv Khanduja, Niklas Feldhahn, Joo Y. Song, Wing C. Chan, Jianjun Chen, M. Mark Taketo, Hilde Schjerven, Julia Jellusova, Shalin Kothari, Matthew S Davids, Markus Müschen
Journal: Blood (2023)
Adverse Prognostic Role of Copy Number Alterations and Mutations in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Authors: Jae-Ho Yoon, Daehun Kwag, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Seok Lee
Journal: Blood (2023)
Deciphering the Impact of Donor Telomere Length on Allogeneic Transplantation Outcomes: Telomere Length Matters More Than Age
Authors: Hengwei Wu, Zhiyang Yuan, Xiang Xu, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Yamin Tan, Huarui Fu, Pengxu Qian, Zhongzheng Zheng, He Huang, Yanmin Zhao
Journal: Blood (2023)
Outcomes of Veterans with FMS-like Tyrosine Kinase 3 Mutated (mFLT3) Acute Myeloid Leukemia (AML) Treated with Novel FLT3 Inhibitors (FLT3i) within the Veterans Health Administration (VHA)
Authors: Eduardo Garcia, Amy M Horowitz, Kathleen Franklin, Michael Mader, Supreet Kaur
Journal: Blood (2023)
Contribution of Genetic Screening to the Diagnosis of Patients with Bone Marrow Failure and Short Telomeres
Authors: Thaís B. Barbosa Rodrigues, Thales D.M. Pereira, Valeria Buccheri, Flavia Donaires, Andre L.P. Santos, Denise C. Paranaguá-Vezozzo, Vanderson Rocha, Rodrigo T. Calado, Elvira Deolinda Rodrigues Pereira Velloso
Journal: Blood (2023)
Real-Life Multicentre Study on 547 Patients Affected By Waldenstrom Macroglobulinemia Treated with Chemo-Immunotherapy: Which Is the Best and Most Used First-Line Treatment?
Authors: Francesco Autore, Alessandra Tedeschi, Giulia Benevolo, Veronica Mattiello, Eugenio Galli, Nicolò Danesin, Rita Rizzi, Jacopo Olivieri, Emanuele Cencini, Benedetta Puccini, Isacco Ferrarini, Dario Marino, Martina Bullo, Bernardo Rossini, Marina Motta, Idanna Innocenti, Luca Stirparo, Diego Petrilli, Raffaella Pasquale, Pellegrino Musto, Greta Scapinello, Alessandro Noto, Veronica Peri, Giulia Zamprogna, Stefan Hohaus, Annamaria Frustaci, Francesco Piazza, Simone Ferrero, Luca Laurenti
Journal: Blood (2023)
Branching Trajectories and Diversification of Clonal Escape in Aplastic Anemia Revealed By Single-Cell Genomics
Authors: Masanori Yoshida, Paula Arnold, Carmelo Gurnari, Charnise Goodings, Shinsuke Hirabayashi, Miriam Erlacher, Jaroslaw P. Maciejewski, Charlotte Marie Niemeyer, Marcin W Wlodarski
Journal: Blood (2023)
Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed/Refractory Follicular Lymphoma: Results from the Phase 1/2 BRUIN Study
Authors: Nirav N. Shah, Pier Luigi Zinzani, Michael L. Wang, Sunita D. Nasta, Ewa Lech-Maranda, Yoshiaki Ogawa, Bita Fakhri, Bryone Kuss, Kaname Miyashita, Krish Patel, Catherine C. Coombs, Shuo Ma, Manish Patel, Minal A. Barve, Benoit Tessoulin, Anastasios Stathis, Won Seog Kim, Daisuke Ennishi, Daigo Hashimoto, Kensuke Kojima, Andrew D. Zelenetz, Jonathon B. Cohen, Julie M. Vose, Kami J. Maddocks, Talha Munir, Fangfang Sun, Faith Bian, Donald E. Tsai, Paolo Abada, Chan Y. Cheah
Journal: Blood (2023)
A Window Study of Acalabrutinib &amp; Rituximab, Followed By Chemotherapy &amp; Autograft (ASCT) in Fit Patients with Treatment Naïve Mantle Cell Lymphoma (MCL): First Report of the Investigator-Initiated Australasian Leukaemia &amp; Lymphoma Group NHL33 ‘Wamm’ Trial
Authors: Eliza A Hawkes, Sze Ting Lee, Leonid Churilov, Tasman Armytage, Georgina Hodges, Chan Yoon Cheah, Joel Wight, Nicole Wong Doo, Matthew Ku, Stephen S. Opat, Tara Cochrane, Greg Hapgood, Hui-Peng Lee, Rishu Agarwal, Wendi Lin, Minu Koshy, Mannu Walia, Liudmyla Olenko, Paul Sung-Hao Yeh, Bianca Devitt, Allison A Barraclough
Journal: Blood (2023)
Prediction of Time-to-First Treatment (TTFT) in Favorable-Risk Chronic Lymphocytic Leukemia (CLL) Patients Using a Novel Stratification through Transcriptome Risk Scoring
Authors: Boyu Hu, Brian Avery, Rosalie Griffin, Julie Feusier, Ahmad Halwani, Justin Williams, Brandt Jones, Michael Madsen, Deborah M. Stephens, Nicola J Camp
Journal: Blood (2023)
Terbutaline Modulates Macrophage Homeostasis and Macrophage-T-Cell Interactions in Immune Thrombocytopenia
Authors: Ye-Jun Wu, Qingyuan Qu, Yuxiu Chen, Menglin Li, Mengyu Xiao, Jianying Zhou, Gaochao Zhang, Haixia Fu, Xiao Jun Huang, Xiaohui Zhang
Journal: Blood (2023)
<i>UBTF</i> Tandem Duplications in Pediatric MDS and AML: Implications for Clinical Screening and Diagnosis
Authors: Juan Barajas, Masayuki Umeda, Jing Ma, Mahsa Khanlari, Michael P Walsh, Tamara Westover, Lisett Contreras, Guangchun Song, Xiaotu Ma, Melvin Thomas, Jeffery M. Klco
Journal: Blood (2023)
Emapalumab for Treatment of Impending Graft Failure
Authors: Anthony Sabulski, Sonata Jodele, Eleanor Cook, Kasiani Myers, Adam C. Lane, Samppa Ryhanen, Maria Pia Cefalo, Francesco Quagliarella, Stella M Davies, Ashley Teusink-Cross, Paibel Aguayo-Hiraldo, Jessie L. Alexander, Paul Szabolcs, Mira Kohorst, Tiziana Corsetti, Franco Locatelli, Pietro Merli
Journal: Blood (2023)
Analytical Validation of a Duplex Sequencing AML Assay with a Limit of Detection Below 0.01% VAF for SNVs and Indels
Authors: Mark A. McElwain, Janice M. Olson, Camila Zanette, Karen Nguyen, Devon M. Fitzgerald, Isabel Y. Lee, Elizabeth Schmidt, Kevin C. Vavra, Laura B. Gillis, Kelly J. Gordon, Wayne B. Wakeman, Thomas H. Smith, Jesse J. Salk, Jake Higgins, Jill C. Harrell, Frances Chu, Gavin D. Meredith
Journal: Blood (2023)